135 related articles for article (PubMed ID: 16122410)
1. [Utility of PET-18FDG in primary tumor site in a patient with cerebral metastases].
Suárez Fernández JP; Serna Macías JA; Domínguez Grande ML; Liaño H; Pozo MA; Maldonado Suárez A
Rev Esp Med Nucl; 2005; 24(4):253. PubMed ID: 16122410
[No Abstract] [Full Text] [Related]
2. Simultaneous demonstration of metabolic lesions consistent with Alzheimer disease and brain metastases on FDG-PET imaging.
Takalkar AM; El-Haddad G; Lilien DL; Patterson JC
Clin Nucl Med; 2008 Jun; 33(6):438-40. PubMed ID: 18496460
[No Abstract] [Full Text] [Related]
3. FDG PET and gallium scintigraphy for diagnosis of an advanced jejunal adenocarcinoma with distant metastases.
Yamaura G; Yoshioka T; Kubota K; Yamaguchi K; Iwata R; Abe T; Kitagawa Y; Kanamaru R; Fukuda H; Ishioka C
Clin Nucl Med; 2004 Dec; 29(12):825-7. PubMed ID: 15545894
[No Abstract] [Full Text] [Related]
4. Diagnostic value of fluorine 18 fluorodeoxyglucose positron emission tomography/computed tomography for the detection of metastases in non-small-cell lung cancer patients.
Wu Y; Li P; Zhang H; Shi Y; Wu H; Zhang J; Qian Y; Li C; Yang J
Int J Cancer; 2013 Jan; 132(2):E37-47. PubMed ID: 22890912
[TBL] [Abstract][Full Text] [Related]
5. Limitation of F-18 fluorodeoxyglucose positron emission tomography in the detection of metastatic adenocarcinoma of brain combining intratumoral hemorrhage.
Miyamoto J; Owada K; Sasajima H; Mineura K
Clin Nucl Med; 2010 Jul; 35(7):554-6. PubMed ID: 20548160
[No Abstract] [Full Text] [Related]
6. Impact of PET/CT on clinical management in patients with cancer of unknown primary-a PET/CT registry study.
Reinert CP; Sekler J; la Fougère C; Pfannenberg C; Gatidis S
Eur Radiol; 2020 Mar; 30(3):1325-1333. PubMed ID: 31728688
[TBL] [Abstract][Full Text] [Related]
7. [Bone metastases from unknown primary. FDG-PET detection of two synchronous tumors].
Cuenca Cuenca JI; Borrego Dorado I; Rodríguez Rodríguez JR; Navarro González E; Vázquez Albertino R
Rev Esp Med Nucl; 2007; 26(5):297-302. PubMed ID: 17910839
[TBL] [Abstract][Full Text] [Related]
8. Pure ground glass nodular adenocarcinomas: Are preoperative positron emission tomography/computed tomography and brain magnetic resonance imaging useful or necessary?
Cho H; Lee HY; Kim J; Kim HK; Choi JY; Um SW; Lee KS
J Thorac Cardiovasc Surg; 2015 Sep; 150(3):514-20. PubMed ID: 26189165
[TBL] [Abstract][Full Text] [Related]
9. FDG-PET imaging in duodenal cancer.
Watanabe N; Hayashi S; Kato H; Shimizu M; Kamisaki Y; Noguchi K; Kishida M; Matsunari I; Hisada K; Seto H
Ann Nucl Med; 2004 Jun; 18(4):351-3. PubMed ID: 15359930
[TBL] [Abstract][Full Text] [Related]
10. [Clinical application of positron emission tomography and 18FDG to brain tumor].
Momose T
Nihon Rinsho; 2005 Sep; 63 Suppl 9():242-9. PubMed ID: 16201530
[No Abstract] [Full Text] [Related]
11. Metastatic thyroid cancer occurring as an unknown primary lesion: the role of F-18 FDG positron emission tomography.
Dede F; Ajoedi ND; Ansari SM; Jana S; Heiba SI; Abdel-Dayem HM
Clin Nucl Med; 2001 May; 26(5):396-9. PubMed ID: 11317017
[TBL] [Abstract][Full Text] [Related]
12. Detection of unknown primary tumours in patients with cerebral metastases using whole-body 18F-flouorodeoxyglucose positron emission tomography.
Klee B; Law I; Højgaard L; Kosteljanetz M
Eur J Neurol; 2002 Nov; 9(6):657-62. PubMed ID: 12453082
[TBL] [Abstract][Full Text] [Related]
13. Performance of fluorodeoxyglucose-positron-emission tomography/computed tomography for evaluating tumor response to nonsurgical treatment.
Ishihara K; Kobayashi Y; Iwano M; Shiiba M; Yoshihara H; Satoh H; Akiyama K; Kumita S
J Nippon Med Sch; 2011; 78(5):272-3. PubMed ID: 22041872
[No Abstract] [Full Text] [Related]
14. Detection of unknown occult primary tumors using positron emission tomography.
Kole AC; Nieweg OE; Pruim J; Hoekstra HJ; Koops HS; Roodenburg JL; Vaalburg W; Vermey A
Cancer; 1998 Mar; 82(6):1160-6. PubMed ID: 9506364
[TBL] [Abstract][Full Text] [Related]
15. PET/CT findings for bone marrow carcinosis because of lung adenocarcinoma.
Watanabe K; Shinkai M; Nagai K; Yamaguchi N; Ishigatsubo Y; Kaneko T
J Thorac Oncol; 2013 Nov; 8(11):1456-7. PubMed ID: 24128717
[No Abstract] [Full Text] [Related]
16. 18F-FDG whole body positron emission tomography (PET) in patients with unknown primary tumours (UPT).
Lassen U; Daugaard G; Eigtved A; Damgaard K; Friberg L
Eur J Cancer; 1999 Jul; 35(7):1076-82. PubMed ID: 10533451
[TBL] [Abstract][Full Text] [Related]
17. FDG-PET/CT of Vulvar Adenocarcinoma With Diffuse Metastases.
Patel D; Anderson TM; Lu Y
Clin Nucl Med; 2016 Sep; 41(9):710-1. PubMed ID: 27187733
[TBL] [Abstract][Full Text] [Related]
18. A case of cerebral metastases of unknown origin: utility of F-18 FDG positron emission tomography to localize the primary tumor.
Belhocine T; Bolle S; Alberini JL; Daenen F; Rutten I; Rigo P
Clin Nucl Med; 2001 Sep; 26(9):793. PubMed ID: 11507305
[No Abstract] [Full Text] [Related]
19. Usefulness 18F-FDG positron emission tomography/computed tomography for detecting recurrence of hepatocellular carcinoma in posttransplant patients.
Kim YK; Lee KW; Cho SY; Han SS; Kim SH; Kim SK; Park SJ
Liver Transpl; 2010 Jun; 16(6):767-72. PubMed ID: 20517911
[TBL] [Abstract][Full Text] [Related]
20. Antibody-positive paraneoplastic neurologic syndromes: value of CT and PET for tumor diagnosis.
Linke R; Schroeder M; Helmberger T; Voltz R
Neurology; 2004 Jul; 63(2):282-6. PubMed ID: 15277621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
